Merle-Béral H - Search Results

1

IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.

Maloum K, Settegrana C, Chapiro E, Cazin B, Leprêtre S, Delmer A, Leporrier M, Dreyfus B, Tournilhac O, Mahe B, Nguyen-Khac F, Lesty C, Davi F, Merle-Béral H. Maloum K, et al. Ann Hematol. 2009 Dec;88(12):1215-21. doi: 10.1007/s00277-009-0742-6. Epub 2009 Apr 2. Ann Hematol. 2009. PMID: 19340428

2

Alternating chemotherapy and radiation therapy in the treatment of advanced Hodgkin's disease.

Grigoraki V, Merle-Beral H, Touboul E, Gabarre J, Lesty C, Binet JL. Grigoraki V, et al. Nouv Rev Fr Hematol (1978). 1988;30(4):219-24. Nouv Rev Fr Hematol (1978). 1988. PMID: 3194187

3

Skewed rearrangement of the VH4-21 gene during pre-B acute lymphoblastic leukemia.

Maloum K, Magnac C, Pritsch O, Binet JL, Merle-Béral H, Dighiero G. Maloum K, et al. Leuk Lymphoma. 1995 May;17(5-6):435-41. doi: 10.3109/10428199509056854. Leuk Lymphoma. 1995. PMID: 7549834

4

Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia.

Maloum K, Davi F, Magnac C, Pritsch O, McIntyre E, Valensi F, Binet JL, Merle-Béral H, Dighiero G. Maloum K, et al. Blood. 1995 Nov 15;86(10):3883-90. Blood. 1995. PMID: 7579357 Free article.

5

Basket cells or shadow cells of Gumprecht: a scanning electron microscope study, and the correlation between percentages of basket cells, and cells with altered chromatin structure (dense cells), in chronic lymphocytic leukemia.

Binet JL, Baudet S, Mentz F, Chevance A, Lesty C, Blanc C, Michel A, Merle-Beral H. Binet JL, et al. Blood Cells. 1993;19(3):573-81; discussion 582-9. Blood Cells. 1993. PMID: 8018940

6

High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemia.

Davi F, Maloum K, Michel A, Pritsch O, Magnac C, Macintyre E, Salomon-Nguyen F, Binet JL, Dighiero G, Merle-Béral H. Davi F, et al. Blood. 1996 Nov 15;88(10):3953-61. Blood. 1996. PMID: 8916962 Free article.

7

What does apoptosis mean in CLL?

Binet JL, Plunkett W, Robertson B, Merle-Beral H, Mentz F, Hoffbrand AV, Panayiotidis P. Binet JL, et al. Leuk Lymphoma. 1996 Oct;22 Suppl 2:47-52. doi: 10.3109/10428199609102702. Leuk Lymphoma. 1996. PMID: 9021708 Review. No abstract available.

8

VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies.

Maloum K, Pritsch O, Magnac C, Davi F, Binet JL, Merle-Beral H, Dighiero G. Maloum K, et al. Leuk Lymphoma. 1997 Feb;24(5-6):437-48. doi: 10.3109/10428199709055582. Leuk Lymphoma. 1997. PMID: 9086435 Review.

9

What do chronic B cell malignancies teach us about B cell subsets?

Pritsch O, Maloum K, Magnac C, Davi F, Binet JL, Merle-Béral H, Dighiero G. Pritsch O, et al. Chem Immunol. 1997;67:85-101. doi: 10.1159/000058680. Chem Immunol. 1997. PMID: 9212500 Review. No abstract available.

10

Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells.

Davi F, Faili A, Gritti C, Blanc C, Laurent C, Sutton L, Schmitt C, Merle-Béral H. Davi F, et al. Blood. 1997 Nov 15;90(10):4014-21. Blood. 1997. PMID: 9354670 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters